Rating History for BridgeBio Oncology Therapeutics, In (BBOT) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/8/2026 | Priyanka Grover | New Coverage | Overweight (N/A) |
27.00 (N/A) |
8.41 (8.56) |
1.78% | Details |
